PDL1 expression and its correlation with outcomes in non-metastatic triple-negative breast cancer (TNBC)

PURPOSE: Triple-negative breast cancer (TNBC) has a poor outcome compared to other subtypes, even in those with early disease. Immune checkpoint inhibitors (ICIs) have been approved in metastatic diseases and are being tested as a neoadjuvant strategy also. The response to ICIs is largely determined...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ecancermedicalscience
Main Authors: Ghosh, Joydeep, Chatterjee, Meheli, Ganguly, Sandip, Datta, Anupurva, Biswas, Bivas, Mukherjee, Geetashree, Agarwal, Sanjit, Ahmed, Rosina, Chatterjee, Sanjoy, Dabkara, Deepak
Formato: Artigo
Idioma:Inglês
Publicado em: Cancer Intelligence 2021
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8183644/
https://ncbi.nlm.nih.gov/pubmed/34158821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2021.1217
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados